Global Myasthenia Gravis Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Myasthenia Gravis Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Myasthenia Gravis Market Overview:
Global Myasthenia Gravis Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Myasthenia Gravis involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Myasthenia Gravis Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Myasthenia Gravis market in 2020.
Global Myasthenia Gravis Market Segmentation
By Type, Myasthenia Gravis market has been segmented into:
Drug Treatment
Rapid Immunotherapies
By Application, Myasthenia Gravis market has been segmented into:
Hospitals
Clinics
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Myasthenia Gravis market are:
Shire
F. Hoffmann-La Roche
CSL Behring
Grifols
Alexion Pharmaceutical
Avadel Pharmaceuticals
Baxter International
Novartis
Valeant Pharmaceuticals International
Takeda Pharmaceutical Company
1. Market Overview of Myasthenia Gravis
1.1 Myasthenia Gravis Market Overview
1.1.1 Myasthenia Gravis Product Scope
1.1.2 Market Status and Outlook
1.2 Myasthenia Gravis Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Myasthenia Gravis Historic Market Size by Regions (2015-2020)
1.4 Myasthenia Gravis Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Myasthenia Gravis Sales Market by Type (2015-2026)
2.1 Global Myasthenia Gravis Historic Market Size by Type (2015-2020)
2.2 Global Myasthenia Gravis Forecasted Market Size by Type (2021-2026)
2.3 Drug Treatment
2.4 Rapid Immunotherapies
3. Covid-19 Impact Myasthenia Gravis Sales Market by Application (2015-2026)
3.1 Global Myasthenia Gravis Historic Market Size by Application (2015-2020)
3.2 Global Myasthenia Gravis Forecasted Market Size by Application (2021-2026)
3.3 Hospitals
3.4 Clinics
3.5 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Myasthenia Gravis Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Myasthenia Gravis Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Myasthenia Gravis Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Myasthenia Gravis Business
5.1 Shire
5.1.1 Shire Company Profile
5.1.2 Shire Myasthenia Gravis Product Specification
5.1.3 Shire Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Company Profile
5.2.2 F. Hoffmann-La Roche Myasthenia Gravis Product Specification
5.2.3 F. Hoffmann-La Roche Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 CSL Behring
5.3.1 CSL Behring Company Profile
5.3.2 CSL Behring Myasthenia Gravis Product Specification
5.3.3 CSL Behring Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Grifols
5.4.1 Grifols Company Profile
5.4.2 Grifols Myasthenia Gravis Product Specification
5.4.3 Grifols Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Alexion Pharmaceutical
5.5.1 Alexion Pharmaceutical Company Profile
5.5.2 Alexion Pharmaceutical Myasthenia Gravis Product Specification
5.5.3 Alexion Pharmaceutical Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Avadel Pharmaceuticals
5.6.1 Avadel Pharmaceuticals Company Profile
5.6.2 Avadel Pharmaceuticals Myasthenia Gravis Product Specification
5.6.3 Avadel Pharmaceuticals Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Baxter International
5.7.1 Baxter International Company Profile
5.7.2 Baxter International Myasthenia Gravis Product Specification
5.7.3 Baxter International Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Novartis
5.8.1 Novartis Company Profile
5.8.2 Novartis Myasthenia Gravis Product Specification
5.8.3 Novartis Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Valeant Pharmaceuticals International
5.9.1 Valeant Pharmaceuticals International Company Profile
5.9.2 Valeant Pharmaceuticals International Myasthenia Gravis Product Specification
5.9.3 Valeant Pharmaceuticals International Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Takeda Pharmaceutical Company
5.10.1 Takeda Pharmaceutical Company Company Profile
5.10.2 Takeda Pharmaceutical Company Myasthenia Gravis Product Specification
5.10.3 Takeda Pharmaceutical Company Myasthenia Gravis Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Myasthenia Gravis Market Size (2015-2026)
6.2 North America Myasthenia Gravis Key Players in North America (2015-2020)
6.3 North America Myasthenia Gravis Market Size by Type (2015-2020)
6.4 North America Myasthenia Gravis Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Myasthenia Gravis Market Size (2015-2026)
7.2 East Asia Myasthenia Gravis Key Players in North America (2015-2020)
7.3 East Asia Myasthenia Gravis Market Size by Type (2015-2020)
7.4 East Asia Myasthenia Gravis Market Size by Application (2015-2020)
8. Europe
8.1 Europe Myasthenia Gravis Market Size (2015-2026)
8.2 Europe Myasthenia Gravis Key Players in North America (2015-2020)
8.3 Europe Myasthenia Gravis Market Size by Type (2015-2020)
8.4 Europe Myasthenia Gravis Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Myasthenia Gravis Market Size (2015-2026)
9.2 South Asia Myasthenia Gravis Key Players in North America (2015-2020)
9.3 South Asia Myasthenia Gravis Market Size by Type (2015-2020)
9.4 South Asia Myasthenia Gravis Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Myasthenia Gravis Market Size (2015-2026)
10.2 Southeast Asia Myasthenia Gravis Key Players in North America (2015-2020)
10.3 Southeast Asia Myasthenia Gravis Market Size by Type (2015-2020)
10.4 Southeast Asia Myasthenia Gravis Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Myasthenia Gravis Market Size (2015-2026)
11.2 Middle East Myasthenia Gravis Key Players in North America (2015-2020)
11.3 Middle East Myasthenia Gravis Market Size by Type (2015-2020)
11.4 Middle East Myasthenia Gravis Market Size by Application (2015-2020)
12. Africa
12.1 Africa Myasthenia Gravis Market Size (2015-2026)
12.2 Africa Myasthenia Gravis Key Players in North America (2015-2020)
12.3 Africa Myasthenia Gravis Market Size by Type (2015-2020)
12.4 Africa Myasthenia Gravis Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Myasthenia Gravis Market Size (2015-2026)
13.2 Oceania Myasthenia Gravis Key Players in North America (2015-2020)
13.3 Oceania Myasthenia Gravis Market Size by Type (2015-2020)
13.4 Oceania Myasthenia Gravis Market Size by Application (2015-2020)
14. South America
14.1 South America Myasthenia Gravis Market Size (2015-2026)
14.2 South America Myasthenia Gravis Key Players in North America (2015-2020)
14.3 South America Myasthenia Gravis Market Size by Type (2015-2020)
14.4 South America Myasthenia Gravis Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Myasthenia Gravis Market Size (2015-2026)
15.2 Rest of the World Myasthenia Gravis Key Players in North America (2015-2020)
15.3 Rest of the World Myasthenia Gravis Market Size by Type (2015-2020)
15.4 Rest of the World Myasthenia Gravis Market Size by Application (2015-2020)
16 Myasthenia Gravis Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Myasthenia Gravis Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|